63 completed. 63 Phase 3, 7 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 63 | Completed 63 |
| Phase 2 | 7 | Completed 7 |
Follow Suppuration: new trials by email Literature Review of Suppuration trials Research Report on Suppuration
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate the Efficacy and Safety of Subcutaneous Sonelokimab Compared With Placebo in Adult Participants With Moderate to Severe Hidradenitis Suppurativa Sonelokimab, Placebo - Hidradenitis Suppurativa | Phase 3 | Completed | MoonLake Immunotherapeutics AG | 422 | 2024-05-15 | 2026-08-12 |
| Study to Evaluate the Efficacy and Safety of Subcutaneous Sonelokimab Compared With Placebo in Adult Participants With Moderate to Severe Hidradenitis Suppurativa Sonelokimab, Placebo - Hidradenitis Suppurativa | Phase 3 | Completed | MoonLake Immunotherapeutics AG | 418 | 2024-05-14 | 2026-06-08 |
| Lunsayil 1: A Study to Test Whether Spesolimab Helps People With a Skin Disease Called Hidradenitis Suppurativa Spesolimab i.v., Spesolimab s.c., Placebo matching Spesolimab i.v. - Hidradenitis Suppurativa | Phase 2 / Phase 3 | Completed | Boehringer Ingelheim | 209 | 2023-04-17 | 2025-11-05 |
| A Study to Evaluate the Efficacy and Safety of Povorcitinib (INCB054707) in Participants With Moderate to Severe Hidradenitis Suppurativa (HS) Povorcitinib, Placebo - Hidradenitis Suppurativa (HS) | Phase 3 | Completed | Incyte Corporation | 619 | 2023-02-22 | 2026-01-09 |
| A Study to Evaluate the Efficacy and Safety of Povorcitinib (INCB054707) in Participants With Moderate to Severe Hidradenitis Suppurativa Povorcitinib, Placebo - Hidradenitis Suppurativa (HS) | Phase 3 | Completed | Incyte Corporation | 608 | 2022-12-19 | 2026-02-10 |
| Effects of 100% Medical Grade Manuka Honey on Tympanic Membrane Reconstruction Healing. Manukamed - Manukapli 100% sterile honey wound dressing - Premium medical grade 16+ Leptospermum Scoparium New Zealand honey - Otitis Media, Suppurative, Tympanic Membrane Perforation | Phase 2 / Phase 3 | Completed | Fakultas Kedokteran Universitas Indonesia | 64 | 2021-06-13 | 2022-11-04 |
| A Study to Test the Long-term Treatment of Bimekizumab in Study Participants With Moderate to Severe Hidradenitis Suppurativa Bimekizumab - Hidradenitis Suppurativa | Phase 3 | Completed | UCB Biopharma SRL | 658 | 2021-05-27 | 2026-10-06 |
| Metformin for the Treatment of Hidradenitis Suppurativa (HS) Metformin - Hidradenitis Suppurativa | Phase 3 | Completed | K.R. van Straalen | 62 | 2021-01-25 | 2023-10-11 |
| Extension Study to Assess Effects of Non-interrupted Versus Interrupted and Long Term Treatment of Two Dose Regimes of Secukinumab in Subjects With Hidradenitis Suppurativa secukinumab - Hidradenitis Suppurativa | Phase 3 | Completed | Novartis Pharmaceuticals | 702 | 2020-03-18 | 2026-08-21 |
| A Study to Evaluate the Efficacy and Safety of Bimekizumab in Study Participants With Moderate to Severe Hidradenitis Suppurativa Bimekizumab, Placebo - Hidradenitis Suppurativa | Phase 3 | Completed | UCB Biopharma SRL | 509 | 2020-03-02 | 2026-10-26 |
| A Study to Evaluate the Efficacy and Safety of Bimekizumab in Study Participants With Moderate to Severe Hidradenitis Suppurativa Bimekizumab, Placebo - Hidradenitis Suppurativa | Phase 3 | Completed | UCB Biopharma SRL | 505 | 2020-02-19 | 2026-10-26 |
| Intranasal Fentanyl as an Adjunct to Lidocaine Infiltration in Adults Undergoing Abscess Incision and Drainage Intranasal fentanyl, Placebo - Abscess | Phase 3 | Completed | Montefiore Medical Center | 49 | 2019-08-01 | 2023-08-15 |
| Effectiveness Study of Ketoconazole and Betamethasone to Treat Fungal Infection and Dermatophytosis Candicort®, Nizoral®, Baycuten N® - Tinea | Phase 3 | Completed | Ache Laboratorios Farmaceuticos S.A. | 125 | 2019-06-11 | 2021-09-20 |
| Study of Efficacy and Safety of Two Secukinumab Dose Regimens in Subjects With Moderate to Severe Hidradenitis Suppurativa (HS) Secukinumab, Placebo - Hidradenitis Suppurativa | Phase 3 | Completed | Novartis Pharmaceuticals | 545 | 2019-02-25 | 2024-10-09 |
| This Was a Study of Efficacy and Safety of Two Secukinumab Dose Regimens in Subjects With Moderate to Severe Hidradenitis Suppurativa (HS). secukinumab, Placebo - Hidradenitis Suppurativa | Phase 3 | Completed | Novartis Pharmaceuticals | 544 | 2019-01-31 | 2024-10-09 |
| The Effects of Iontophoresis in Women With Gynoid Hidrolipodystrophy. iontophoresis + caffeine - Caffeine, Cellulitis | Phase 2 / Phase 3 | Completed | Universidade Norte do Paraná | 30 | 2018-06-14 | 2019-04-16 |
| Cantharidin Application in Molluscum Patients-1 VP-102 - Cantharidin, Topical Film Forming Solution, Placebo -Topical Film Forming Solution without VP-102 - Molluscum Contagiosum | Phase 3 | Completed | Verrica Pharmaceuticals Inc. | 266 | 2018-03-21 | 2022-01-11 |
| Cantharidin Application in Molluscum Patients VP-102 - Cantharidin, Topical Film Forming Solution, Placebo -Topical Film Forming Solution without VP-102 - Molluscum Contagiosum | Phase 3 | Completed | Verrica Pharmaceuticals Inc. | 262 | 2018-02-14 | 2021-12-14 |
| Resolution of Pain and Swelling After the Use of Neem Leaf Extract Compared to Chlorhexidine Gluconate as an Intracanal Irrigant During Pulpectomy Neem leaf extract, Chlorhexidine gluconate - Periapical Abscess | Phase 2 / Phase 3 | Completed | Cairo University | 40 | 2016-12-01 | 2019-07-31 |
| Open-label Study of Adalimumab in Japanese Subjects With Hidradenitis Suppurativa adalimumab - Hidradenitis Suppurativa | Phase 3 | Completed | AbbVie | 15 | 2016-09-06 | 2020-05-12 |
Showing 20 of 63. Sign in to see all of them.
Cellulitis (32) · Abscess (16) · Hidradenitis Suppurativa (16) · Wound Infection (9) · Skin Diseases, Bacterial (8) · Skin Diseases (7) · Bacterial Infections (6) · Surgical Wound Infection (6) · Infections (5) · Hidradenitis (4) · Abdominal Abscess (3) · Acne Vulgaris (3) · Empyema (3) · Staphylococcal Infections (3) · Diabetic Foot (2)
Infections (58) · Skin and Connective Tissue Diseases (49) · Pathologic Processes (46) · Pathological Conditions, Signs and Symptoms (46) · Skin Diseases, Infectious (46) · Inflammation (44) · Connective Tissue Diseases (32) · Bacterial Infections and Mycoses (28) · Skin Diseases (24) · Bacterial Infections (21) · Skin Diseases, Bacterial (16) · Sweat Gland Diseases (14) · Hidradenitis (12) · Gram-Positive Bacterial Infections (7)
Vancomycin (11) · Aztreonam (5) · Adalimumab (4) · Linezolid (4) · Moxifloxacin (4) · Ceftaroline (3) · Tigecycline (3) · bimekizumab (3) · dalbavancin (3) · secukinumab (3) · Amoxicillin-Potassium Clavulanate Combination (2) · Daptomycin (2) · Levofloxacin (2) · Thoracic Surgery, Video-Assisted (2) · Trimethoprim, Sulfamethoxazole Drug Combination (2)
Novartis Pharmaceuticals (4) · AbbVie (prior sponsor, Abbott) (3) · Durata Therapeutics Inc., an affiliate of Allergan plc (3) · Melinta Therapeutics, Inc. (3) · UCB Biopharma SRL (3) · Wyeth is now a wholly owned subsidiary of Pfizer (3) · Arpida AG (2) · Bayer (2) · Forest Laboratories (2) · GlaxoSmithKline (2) · Incyte Corporation (2) · Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (2) · MoonLake Immunotherapeutics AG (2) · Pfizer (2) · Verrica Pharmaceuticals Inc. (2)
United States (35) · Germany (21) · Poland (17) · Canada (16) · Spain (16) · France (14) · Bulgaria (13) · Russia (13) · Italy (12) · Belgium (11) · United Kingdom (11) · Greece (10) · Hungary (10) · Israel (10) · Netherlands (10)
G. Ralph Corey, MD (2) · Lawrence Eichenfield, MD (2) · Michael Dunne, MD (2) · Prof Kristian Reich, M.D., Ph.D. (equ.) (2) · Adele Sparavigna, Doctor (1) · Andrea Cruz, MD, MPH (1) · Benjamin Friedman, MD (1)
PMID 30597021, PMID 30716446, PMID 34741280, PMID 34905144, PMID 34922058, PMID 41248770, PMID 42482599, PMID 42525209, PMID 20695801, PMID 21115456, PMID 24897082, PMID 27370913, PMID 27518661, PMID 29358292, PMID 29380251, PMID 32965495, PMID 33599960, PMID 34976290, PMID 36746171, PMID 38795716, PMID 39101698, PMID 39141589, PMID 39425517, PMID 40153232, PMID 40172122, PMID 40372667, PMID 40652434, PMID 40839197, PMID 41107641, PMID 41689425, PMID 42247110, PMID 42493571, PMID 12145720, PMID 19036670, PMID 19036671, PMID 19220646, PMID 20346539, PMID 20663130, PMID 21115454, PMID 21115455, PMID 21896561, PMID 22265220, PMID 23180507, PMID 24010809, PMID 24439136, PMID 24797294, PMID 24897083, PMID 25294250, PMID 25396674, PMID 26409714
2018 (2), 2019 (2), 2009 (1), 2023 (1)